Unraveling AURKB as a potential therapeutic target in pulmonary hypertension using integrated transcriptomic analysis and pre-clinical studies
Sarah‐Eve Lemay(SNC-Lavalin (Canada)), Olivier Boucherat(Lung Institute), Chanil Valasarajan(Universities of Giessen and Marburg Lung Center), Mégan Gilbert, François Potus(Queen's University), Yann Grobs(Institut universitaire de cardiologie et de pneumologie de Québec), Sandra Martineau(Canadian Heart Research Centre), Steeve Provencher(Institut universitaire de cardiologie et de pneumologie de Québec), Sébastien Bonnet(Institut universitaire de cardiologie et de pneumologie de Québec), Charlotte Romanet(Canadian Heart Research Centre), Soni Savai Pullamsetti(Justus-Liebig-Universität Gießen), Sandra Breuils‐Bonnet, Mélanie Sauvaget(Canadian Heart Research Centre), Manon Mougin(Canadian Heart Research Centre), Reem El Kabbout(Canadian Heart Research Centre), Charlie Théberge(Canadian Heart Research Centre), Min Lü(Central South University), Keiko Yamamoto(Hesco (United States)), Andréanne Pelletier(Canadian Heart Research Centre), Mónica S. Montesinos(Universidad de La Laguna), Alice Bourgeois, Huidong Chen
Cited by 8
Related Papers
A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer Growth
|Cancer Cell|2007|1.5k
The Crucial Role of Chromogranins in Storage and Exocytosis Revealed Using Chromaffin Cells from Chromogranin A Null Mouse
|Journal of Neuroscience|2008|130
Novel Mutations and Decreased Expression of the Epigenetic Regulator <i>TET2</i> in Pulmonary Arterial Hypertension
|Circulation|2020|120
Interferon-α targets JAK2V617F-positive hematopoietic progenitor cells and acts through the p38 MAPK pathway
|Experimental Hematology|2010|77
Defining the clinical validity of genes reported to cause pulmonary arterial hypertension
|Genetics in Medicine|2023|73